pubmed.ncbi.nlm.nih.gov

Crohn's disease: innate immunodeficiency? - PubMed

  • ️Sun Jan 01 2006

Review

Crohn's disease: innate immunodeficiency?

Jesus-K Yamamoto-Furusho et al. World J Gastroenterol. 2006.

Abstract

In the past, Crohn's disease (CD) has been understood primarily as an immunologic disorder characterized by an abnormal T-cell response. Recent in vitro and in vivo data suggests that CD may instead be precipitated by innate immune dysfunction resulting from a combination of genetic and environmental factors. Some reports have demonstrated a defective immune response in a variety of other cellular components, including neutrophils, monocytes and dendritic cells. Recent studies of granulocyte-macrophage colony-stimulating factor (GM-CSF) in CD, aiming to stimulate the innate immune system with the conception that an innate immune defect underlies the development of the disease, have been demonstrated a clinical benefit and reinforce this evolving understanding of the disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Impairment of different innate immune mechanisms. These mechanisms play a central role in the homeostasis of intestinal barrier function. Identified environmental risks and genetic susceptibility may contribute to the innate immune dysfunction.

Figure 2
Figure 2

Targets of immunostimulation therapy in Crohn’s disease. Potential therapies encompass interventions focused on augmenting the intestinal innate immune function in different mechanisms of action.

Similar articles

Cited by

References

    1. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276:4812–4818. - PubMed
    1. Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut. 2003;52:1591–1597. - PMC - PubMed
    1. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 2003;278:5509–5512. - PubMed
    1. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869–8872. - PubMed
    1. Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol. 2005;170:21–26. - PMC - PubMed

Publication types

MeSH terms

Substances